UnknownPhase 3

Paraspinal Stimulation in Treating MPS

Brazil75 participantsStarted 2011-01

Plain-language summary

To test the hypothesis that the effect of either multiple deep intramuscular stimulation therapy \[(DIMMST: trigger point deep dry needling (TrP-DDN) is combined with paraspinal deep intramuscular stimulation (PDIMS) and needle rotation (NR)\] would be more effective than a placebo-sham for the treatment of MPS and that DIMMST would be more effective than LTrP-I for improving pain relief, sleep quality, and physical and mental state of the patient.

Who can participate

Age range19 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * Myofascial pain syndrome (MPS) (defined as regional pain, normal neurologic examination, presence of TrPs, taut bands, tender points, and pain characterized as "dull," "achy," or "deep" were relevant to MPS diagnosis. Additionally, palpable nodules, pain that is exacerbated by stress, decreased range of motion, and ropiness in the muscle). * Disability in the last three months: (defined if they had one or more these limitation in active and routine activities by MPS : (i) interference with work, (ii) enjoyable activities, (iii) responsibilities at home, (iv) relationships, (v) personal goals, (vi) thinking clearly, and problem solving, concentrating, or remembering during the last three months). * Women * Age: 19 to 50 years Exclusion criteria Rheumatoid arthritis Fibromyalgia Previous surgery on the affected areas Prior experience with acupuncture Primary radiculopathy Current use of psychotropic drugs (ilicits ) Habitual use of anti-inflammatory steroids.

What they're measuring

Pain severity

Timeframe: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)

Pain threshold

Timeframe: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)

Trial details

NCT IDNCT01708343

SponsorHospital de Clinicas de Porto Alegre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-11

Contact for this trial

WOLNEI CAUMO, MD, PhD

55-51-3359-8083 caumo@cpovo.net

View on ClinicalTrials.gov More Clinical Study - RCT trials

Plain-language summary

Who can participate

Age range19 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Pain severity

Timeframe: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)

Pain threshold

Timeframe: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)